Aurinia Pharmaceuticals
AUPH
#5292
Rank
C$1.60 B
Marketcap
$11.67
Share price
1.74%
Change (1 day)
69.30%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): C$16.8 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are C$0.23 Billion. , an increase over its 2023 earnings that were of -C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 C$17.49 M-116.44%
2023 -C$0.11 Billion-31.8%
2022 -C$0.16 Billion-39.4%
2021 -C$0.26 Billion61.9%
2020 -C$0.16 Billion-9.73%
2019 -C$0.18 Billion92.65%
2018 -C$91.44 Million36.39%
2017 -C$67.04 Million106.29%
2016 -C$32.5 Million-15.4%
2015 -C$38.42 Million65.84%
2014 -C$23.17 Million129.82%
2013 -C$10.08 Million-26.6%
2012 -C$13.74 Million
2010 -C$7.78 Million-39.22%
2009 -C$12.8 Million-43.78%
2008 -C$22.76 Million-53.19%
2007 -C$48.61 Million42.97%
2006 -C$34 Million-23.03%
2005 -C$44.18 Million36.1%
2004 -C$32.46 Million172.57%
2003 -C$11.91 Million484.61%
2002 -C$2.04 Million
2000 -C$9.68 Million453.81%
1999 -C$1.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$6.80 B 38,814.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$7.82 Million-144.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$31.51 Million-280.09%๐Ÿ‡บ๐Ÿ‡ธ USA